Crohn’s/Colitis Foundation Launches “IBD Plexus”; Data-Linking Project Is Step Towards Personalized Therapy
This article was originally published in RPM Report
Executive Summary
The Crohn’s and Colitis Foundation of America is working on a platform to aggregate clinical, biosample and derived “omic” data across multiple cohorts. That’s worth watching as another step in the increasingly sophisticated and ambitious efforts by disease advocacy groups to collect, process and share data in specific conditions.
You may also be interested in...
Precision Medicine Is Precisely Right Theme For Biopharma: Impact Of Therapy—Not Cost—Is Focus
A Senate hearing on President Obama’s Precision Medicine initiative illustrates how well that theme plays for the biopharma sector. The focus was on the potential for highly effective targeted therapies to help patients—and even lower costs for the system. The price of the drugs themselves was not even raised.
Is There a Draft In Here? 21st Century Cures Legislation Stumbles At The Starting Line
The House Energy & Commerce Committee released its eagerly awaited first draft of potential legislation to improve the climate for innovation in the US. Or did it? The unexpectedly partisan reaction is a sign of how far the process still has to go – but the overall pro-innovation focus is likely to carry through.
Drug Shortage Could Be Addressed By ‘Resilience Rating’ From Private Entity Under HHS Plan
US HHS is proposing a public-private partnership to assign ratings to manufacturers based on quality/resilience of supply, tied to a purchasing incentive program for providers. The non-agency approach may be key to overcoming industry and political objections.